Logo do repositório
 
Publicação

Strengthening screening for infectious diseases and vaccination among migrants in Europe

2021-01-01Artigo científico Acesso aberto
Ver registo simples
dc.contributor.authorECDC ad hoc scientific panel
dc.contributor.authorNoori, Teymur
dc.contributor.authorHargreaves, Sally
dc.contributor.authorGreenaway, Christina
dc.contributor.authorvan der Werf, Marieke
dc.contributor.authorDriedger, Matt
dc.contributor.authorMorton, Rachael L.
dc.contributor.authorHui, Charles
dc.contributor.authorRequena-Mendez, Ana
dc.contributor.authorAgbata, Eric
dc.contributor.authorMyran, Daniel T.
dc.contributor.authorPareek, Manish
dc.contributor.authorCampos-Matos, Ines
dc.contributor.authorNielsen, Rikke Thoft
dc.contributor.authorSemenza, Jan
dc.contributor.authorNellums, Laura B.
dc.contributor.authorPottie, Kevin
dc.contributor.authorDias, S
dc.contributor.institutionEscola Nacional de Saúde Pública (ENSP)
dc.contributor.pblElsevier
dc.date.accessioned2021-10-13T23:20:11Z
dc.date.available2021-10-13T23:20:11Z
dc.date.issued2021-01-01
dc.descriptionFunding Information: SH is funded by the National Institute for Health Research (NIHR Advanced Fellowship NIHR300072), the Academy of Medical Sciences (SBF005\1111), and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) through an ESCMID Study Group for Infections in Travellers and Migrants (ESGITM) research grant. MP is supported by the National Institute for Health Research (NIHR Post-Doctoral Fellowship, PDF-2015-08-102). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the UK Department of Health. Funding Information: SH is funded by the National Institute for Health Research ( NIHR Advanced Fellowship NIHR300072 ), the Academy of Medical Sciences ( SBF005\1111 ), and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) through an ESCMID Study Group for Infections in Travellers and Migrants ( ESGITM ) research grant. MP is supported by the National Institute for Health Research ( NIHR Post-Doctoral Fellowship , PDF-2015-08-102 ). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the UK Department of Health. Publisher Copyright: © 2020 The Authors
dc.description.abstractMigration to the European Union (EU)/European Economic Area (EEA) affects the epidemiology of infectious diseases, including tuberculosis (TB), HIV, hepatitis B/C, and parasitic diseases. Some sub-populations of migrants are also considered to be an under-immunised group and thus at risk of vaccine-preventable diseases. Providing high-risk migrants access to timely and efficacious screening and vaccination, and understanding how best to implement more integrated screening and vaccination programmes into European health systems ensuring linkage to care and treatment, is key to improving the health of migrants and their communities, alongside meeting national and regional targets for infection surveillance, control, and elimination. The European Centre for Disease Prevention and Control (ECDC) has responded to calls to action to improve migrant health and strengthen universal health coverage by developing evidence-based guidance for policy makers, public health experts, and front-line healthcare professionals on how to approach screening and vaccination in newly arrived migrants within the EU/EEA. In this Commentary, we provide a perspective towards developing efficacious screening and vaccination of newly arrived migrants, with a focus on defining implementation challenges and evidence gaps in high-migrant receiving EU/EEA countries. There is a need now to leverage the increasing momentum around migrant health to both strengthen the evidence-base and to advocate for universal access to health care for all migrants in the EU/EEA, including undocumented migrants. This should include voluntary, confidential, and non-stigmatising screening and vaccination that should be free of charge and facilitate linkage to appropriate care and treatment.en
dc.description.versionpublishersversion
dc.description.versionpublished
dc.format.extent386145
dc.identifier.doi10.1016/j.tmaid.2020.101715
dc.identifier.issn1477-8939
dc.identifier.otherPURE: 34257860
dc.identifier.otherPURE UUID: a02d5f81-e725-4340-a85b-e16b3cc11b95
dc.identifier.otherScopus: 85097401855
dc.identifier.otherPubMed: 32389827
dc.identifier.otherWOS: 000620092200001
dc.identifier.otherORCID: /0000-0001-5085-0685/work/131110309
dc.identifier.urihttp://hdl.handle.net/10362/126082
dc.identifier.urlhttps://www.scopus.com/pages/publications/85097401855
dc.language.isoeng
dc.peerreviewedyes
dc.subjectEurope
dc.subjectInfection
dc.subjectMigrants
dc.subjectScreening
dc.subjectVaccination
dc.subjectPublic Health, Environmental and Occupational Health
dc.subjectInfectious Diseases
dc.subjectSDG 3 - Good Health and Well-being
dc.titleStrengthening screening for infectious diseases and vaccination among migrants in Europeen
dc.title.subtitlewhat is needed to close the implementation gaps?en
dc.typejournal article
degois.publication.titleTravel Medicine and Infectious Disease
degois.publication.volume39
dspace.entity.typePublication
rcaap.rightsopenAccess

Ficheiros

Principais
A mostrar 1 - 1 de 1
Miniatura
Nome:
Noori_Trav_Med_Infect_Dis_2021_39.pdf
Tamanho:
377.09 KB
Formato:
Adobe Portable Document Format
Ver/Abrir

Coleções

Home collection (ENSP)